AzTrials
AzTrials

Evaluation of QL Buttress Plating in QLP Fracture FixationNCT06440590

Supra-Pectineal QLS Plating Vs Infra-pectineal Plating in Management of Quadrilateral Plate Fractures

A study testing suprapectineal quadrilateral buttress plating and Infra-pectineal plating in people with Evaluation of QL Buttress Plating in QLP Fracture Fixation, run by Ain Shams University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The investigators conducted such a prospective randomized controlled study aiming to reach a satisfactory outcome and to compare supra-pectineal QL buttress plating versus infra-pectineal for management of anterior column with or without posterior hemi-transverse component and quadrilateral plate involvement. Read more about this study

Who is it for?
Ages 16 to 60 yearsHealthy volunteers can take part
What is being tested?
suprapectineal quadrilateral buttress plating and Infra-pectineal plating
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteEgypt
Study dates
1 Apr 2023to 20 Aug 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Anterior column fracture acetabulum with QLS involvement
  • Anterior column posterior hemi-transverse fracture acetabulum with QLS involvement
  • Age between 16-60 years' old

Who cannot join

  • Open fractures
  • Associated pelvic ring injuries that require intervention
  • Associated internal organ injuries that require intervention
  • Age less than 14 years and older than 60 years

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Ain Shams university

    Cairo, Abassia, 1234

Other trials in Egypt

About this study

Official title: Supra-Pectineal Quadrilateral Buttress Plating Versus Infra-pectineal Plating in Management of Quadrilateral Plate Fractures: A Randomized Controlled Trial

The investigators conducted such a prospective randomized controlled study aiming to reach a satisfactory outcome and to compare supra-pectineal QL buttress plating versus infra-pectineal for management of anterior column with or without posterior hemi-transverse component and quadrilateral plate involvement.

Read the detailed description

Our hypothesis was that supra-pectineal quadrilateral buttress plating provides much more rigid fixation and a strong buttress for medial wall migration, also it could correlate with a better functional and radiological outcome. However, there is a lack of knowledge in the prospective assessment of functional and radiological outcomes and follow up of postoperative complications of supra-pectineal quadrilateral buttress plating versus infra-pectineal plating in fixation of QLS and to our knowledge, it will be the first study to include such measures of outcome together in a prospective randomized fashion.

Being tested
suprapectineal quadrilateral buttress plating, Infra-pectineal plating
Keywords
quadrilateral plate fractures, anterior column fractures, associated both column fractures, infra-pectineal plating, supra-pectineal quadrilateral buttress plating

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • suprapectineal quadrilateral buttress platingProcedure or surgery

    15 cases will undergo anatomical supra-pectineal quadrilateral plate

  • Infra-pectineal platingProcedure or surgery

    15 cases will undergo conventional manually contoured infra-pectineal plate

Study groups in NCT06440590
Study groupRoleWhat they receive
supra-pectineal quadrilateral buttress platingActive comparatorPatients treated by supra-pectineal quadrilateral buttress plating through anterior intrapelvic approach
Receives: Procedure: suprapectineal quadrilateral buttress plating
Infrapectineal platingActive comparatorPatients treated by infra-pectineal conventional plating applied on the medial wall through anterior intrapelvic approach
Receives: Procedure: Infra-pectineal plating

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of Excellent, very good, Good, Average or Poor functional outcomes using Modified Merle d'Aubigné scoring system

    Clinical assessment was done via Modified Merle d'Aubigné scoring system that was calculated at each follow-up visit (out of 18) and presented the mean value; the score evaluates three factors: pain, mobility \& ability to walk. the score maximum being 18 (excellent) and minimum 6 (poor)

    Measured: one-year post-operative

  2. Rate of Anatomical, Congruent or Incongruent Radiological Outcomes using Matta & Tornetta radiological principles

    Radiological assesment was done according to the grading of Matta and Tornetta, The investigators classified the results into: Anatomical, congruent \& incongruent; based on the restoration of the five anatomical lines (iliopectineal line, ilioischial line, acetabular dome, posterior wall \& anterior wall) \& best judged on the anteroposterior view.

    Measured: 1 year postoperative

  3. Amount of residual displacement

    Residual displacement was measured in millimeters and compared between the two study groups

    Measured: immediate post-operative and throughout study completion

Secondary outcomes (3)
  1. post-operative complications' rate

    The investigators focused the evaluation of Postoperative complications on the local complications related to fixation principles and technique: LLD, AVN of the hip joint, wound infection, residual malunion or non-union of the quadrilateral plate, and loss of reduction

    Measured: 1-year post-operative

  2. Mean intraoperative blood loss

    The mean blood loss was calculated and compared between the two study groups, it was measured intraoperative and postoperative from suction drains

    Measured: up to 4 days post-operative

  3. Mean operative time

    The mean operation time was calculated in minutes and compared between the two study groups

    Measured: it was calculated intra-operative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Jun 2024
  2. Study start1 Apr 2023
  3. Primary completion10 Jul 2024
  4. Study completion20 Aug 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
An independent doctor created the randomization sequence using Excel 2016 (computerized random numbers) with a 1:1 allocation via random block sizes of 2, 4, and 6; he assigned the sample numbers equally to each group and assigned the block. Patients and physicians allocated to each intervention group were aware of the allocation; however, the data analysts and the outcome assessors were kept blinded to the allocation. The investigators prospectively carried out this study on 30 patients with quadrilateral plate fractures between February 2022 and June 2023 that met our inclusion criteria. The independent doctor allocated the 30 cases to two groups: Group A (15 cases): supra-pectineal quadrilateral buttress plating, group B (15 cases): Infra-pectineal plating
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06440590
Sponsor's protocol ID
FMASU R66/2023
Status last verified
Jul 2024
First submitted
26 May 2024
Last updated
30 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: i plan to share it with other researchers

Questions about this trial

What is this clinical trial studying?

A study testing suprapectineal quadrilateral buttress plating and Infra-pectineal plating in people with Evaluation of QL Buttress Plating in QLP Fracture Fixation, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 30 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of Excellent, very good, Good, Average or Poor functional outcomes using Modified Merle d'Aubigné scoring system (time frame: one-year post-operative). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in